Bortezomib For Injection 1mg

Bortezomib for Injection 1 Mg is a treatment for multiple myeloma and mantle cell lymphoma. A trained healthcare provider administers the medication intravenously. Its dosage and frequency of administration will be determined by the patient's medical condition, overall health, and other factors. It represents a single dose of the medication. Bortezomib for Injection 1 Mg is administered in cycles, with periods of treatment followed by periods of rest. Patients taking this medication should be closely monitored for signs of peripheral neuropathy.